WEAV · Weave Communications, Inc.
Market Cap
$586.79M
Shares
80.00M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$7.29
Open$7.34
Day$7.29–7.34
52W close$4.37–7.79
Avg vol 30d4.6M
Short int5.3M · 6.6% float · 1.0d
Short vol65%
Last earningsAug 6, 2026
DataNov 2021–Sep 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Nov 9, 2026
Est · unconfirmed
· in 7 wks
filed Aug 6, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$257.79M
Trailing 12 months
Net income (TTM)
−$20.54M
Trailing 12 months
Revenue growth YoY
+15.5%
Year over year
Operating margin
-8.3%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
2.4%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+5.0%
Year over year · more shares
Price change (1Y)
-5.2%
Trailing year
Short interest
6.6%
Latest settlement · 1.0 days to cover
AI Brief
Q2 FY26 earnings call · Aug 6, 2026
Q2 FY26
TL;DR. Weave reported Q2 revenue of $67.5 million (+15.5% YoY) with record new location adds and a sharp operating margin expansion to 4.7%, but issued full-year 2026 revenue guidance of $273–$275 million reflecting go-to-market transition disruption, while simultaneously raising full-year non-GAAP operating income guidance to $12–$14 million.
Bullish
- + Q2 total revenue grew 15.5% YoY to $67.5 million with payments growing at roughly twice that rate.
- + Added a record number of new locations in Q2, both gross and net, with dental posting its strongest adds in eight quarters.
- + Operating margin expanded to 4.7% from roughly break-even a year ago, exceeding the top end of guidance.
- + Sales and marketing expense improved 240 basis points sequentially as a percentage of revenue.
- + Full-year 2026 non-GAAP operating income guidance was raised to $12–$14 million.
- + Free cash flow was $8.7 million in Q2, up from $4.5 million a year ago.
Bearish
- − Full-year 2026 revenue guidance was set to $273–$275 million, reflecting go-to-market transition disruption that caused May–July bookings to come in below expectations.
- − Q2 GAAP loss from operations was $4.4 million; the company continues to report a GAAP net loss.
- − Q3 revenue guidance of $68.6–$69.6 million reflects only modest sequential growth as booking disruption flows through.
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
High
Market backdrop
VIX 14.8 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+20%
above
Price vs 50-day avg
+7%
above
RSI (14)
61
neutral
MACD trend
Negative
52-week position
85%
near high
Momentum
relative strength
1-month return
0%
trailing
6-month return
+67%
trailing
YTD return
−4%
this year
Relative strength
+47%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $7 › 200d $6 — 50d above 200d
Institutional flow
Accumulating
+2% holders QoQ · +36 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
6.61% of float · ▲ +2.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
185 holders — near 3-yr high, broad support
Squeeze score
52
elevated · 0–100
Fundamentals
Revenue growth
+17%
Y/Y
Gross margin
72%
expanding
EPS growth
+8%
Y/Y
Free cash flow
$15.2M
Balance sheet
$126.0M
net cash
Quant / Vol
risk profile
Volatility
67%
annualized · 1-yr
Max drawdown
−44%
past year
ATR
1.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Jun 30, 2026
full year 2026
Total revenue
Initiated
$273M – $275M
prior FY $239.02M
midpoint +14.6% Y/Y
third quarter of 2026
Total revenue
Initiated
$68.6M – $69.6M
prior qtr $67.54M
midpoint +2.3% QoQ
Operating income
Non-GAAP
Initiated
$3M – $4M
Prior guidance
period ended
· from the Earnings Call filed Dec 31, 2021
Total revenue
· first quarter
$31M – $32M
Total revenue
· full year fiscal 2022
$136M – $140M
Guided vs delivered
· last 2 settled
Total revenue
first quarter
guided $31M – $32M
$33.27M
Beat +5.6%
Total revenue
full year fiscal 2022
guided $136M – $140M
$142.12M
Beat +3.0%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+20%
Bullish
Price vs 50-day avg
+7%
Bullish
RSI (14)
61
Neutral
MACD trend
Negative
Bearish
52-week position
85%
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $7 › 200d $6 — 50d above 200d
Institutional flow
Accumulating
+2% holders QoQ · +36 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
6.61% of float · ▲ +2.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
185 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $4
Now $7 · 85%
Range high $8
vs 200-day avg +20%
vs 50-day avg +7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WEAV
this stock
Weave Communications, Inc.
|
$586.79M | -4.0% | +17.0% | — | 6.6% |
|
VEEV
Veeva Systems Inc
|
$43.69B | +16.6% | +28.1% | 44.2 | 3.0% |
|
TEM
Tempus AI, Inc.
|
$14.05B | +31.8% | +83.4% | — | 16.3% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$12.33B | -28.9% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$11.73B | +51.6% | +28.2% | 35.9 | 5.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WEAV | -0.3% | +0.0% | +66.8% | -0.3% | -4.0% |
| SPY | -0.3% | -0.1% | +20.1% | -0.7% | +11.7% |
| vs SPY | +0.1% | +0.1% | +46.7% | +0.4% | -15.7% |